You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti cancer oral therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oral Mucositis, Pediatric Cancer Trial in Riyadh (Curcumin, Laser)

Not yet recruiting
  • Oral Mucositis
  • Pediatric Cancer
  • Riyadh, Ar Riyadh, Saudi Arabia
    Riyadh Elm University
Sep 15, 2023

Head Neck Cancer Trial in Boston (Oral Decitabine, Durvalumab)

Active, not recruiting
  • Head and Neck Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 30, 2022

Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Bellinzona, London Borough of Sutton (Enzalutamide 40mg,

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Enzalutamide 40mg
  • +4 more
  • Bellinzona, Switzerland
  • +1 more
Nov 6, 2023

Larynx, Lip, Oral Cavity and Pharynx Trial in Philadelphia (Nivolumab, Ipilimumab, Simultaneous-Integrated Boost

Completed
  • Larynx
  • Lip, Oral Cavity and Pharynx
  • Nivolumab
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022

Oral Cavity SCC Trial in Charleston (Nivolumab)

Completed
  • Oral Cavity SCC
  • Charleston, South Carolina
    Medical University of South Carolina
Dec 10, 2021

Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Camrelizumab (anti-PD-1 inhibitor), Apatinib

Recruiting
  • Oral Squamous Cell Carcinoma
  • +3 more
  • Camrelizumab (anti-PD-1 inhibitor)
  • Apatinib (anti-VEGFR inhibitor)
  • Shanghai, Shanghai, China
    Ninth People's Hospital, Shanghai Jiao Tong University School of
Oct 8, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Oral Cancer, VEGFR2 Inhibitor, Programmed Cell Death 1 Inhibitor Trial in Shanghai (drug, procedure, radiation)

Active, not recruiting
  • Oral Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital
Jul 23, 2021

Breast Tumor Female Trial in Beijing (CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou))

Recruiting
  • Breast Neoplasm Female
  • CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou)
  • Beijing, Beijing, China
  • +1 more
Jul 31, 2023

Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

Not yet recruiting
  • Muscle-Invasive Bladder Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center, Sun Yat-sen University
Aug 3, 2023

Gut Microbiome in Anti-tumor Therapy Induced Diarrhea

Recruiting
  • Cancer
    • Graz, Austria
      Department of Internal Medicine, Medical University of Graz
    May 15, 2023

    Colorectal Cancer (CRC), NSCLC (NSCLC) Trial (an enriched high protein and high energy oral nutrition supplement (ONS))

    Not yet recruiting
    • Colorectal Cancer (CRC)
    • Non-small Cell Lung Cancer (NSCLC)
    • an enriched high protein and high energy oral nutrition supplement (ONS)
    • (no location specified)
    Dec 5, 2022

    Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor, Stomatitis Trial in Rochester

    Recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • +2 more
    • Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse
    • Methylene Blue Oral Rinse
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jun 1, 2023

    IBD Trial in Leiden (Ferrous fumarate, MonoFer)

    Recruiting
    • Inflammatory Bowel Diseases
    • Leiden, Zuid-Holland, Netherlands
      Leiden University Medical Centre
    Oct 12, 2022

    Colorectal Cancer Trial (Serplulimab + FOLFOXIRI, Radiation therapy)

    Not yet recruiting
    • Colorectal Cancer
    • Serplulimab + FOLFOXIRI
    • Radiation therapy
    • (no location specified)
    Oct 24, 2023

    Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR

    Completed
    • Metastatic Colorectal Adenocarcinoma
      • (no location specified)
      Oct 9, 2023

      Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

      Completed
      Has Results
      • Recurrent Fallopian Tube Carcinoma
      • +2 more
      • Bevacizumab
      • +3 more
      • Phoenix, Arizona
      • +44 more
      Jan 10, 2022

      Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

      Not yet recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • HP518 - Dose Escalation
      • HP518 -Dose Expansion
      • (no location specified)
      Dec 1, 2023

      Predict Efficacy of Anti-angiogenic Therapy in Ovarian Cancer

      Active, not recruiting
      • Epithelial Ovarian Cancer
      • liquid biopsy
      • Aviano, Italy
        Centro di Riferimento Oncologico (CRO), IRCCS
      May 16, 2023

      Advanced Solid Tumours, Breast Cancer, Head Neck Cancer Trial in France (Durvalumab + Tremelimumab + metronomic Vinorelbine)

      Active, not recruiting
      • Advanced Solid Tumours
      • +4 more
      • Durvalumab + Tremelimumab + metronomic Vinorelbine
      • Angers, France
      • +8 more
      Jun 1, 2022

      Acute Myeloid Leukemia Trial in Philadelphia (Text Message-Based Navigation Intervention, Behavioral, Psychological or

      Recruiting
      • Acute Myeloid Leukemia
      • Text Message-Based Navigation Intervention
      • +3 more
      • Philadelphia, Pennsylvania
      • +1 more
      Oct 25, 2022

      Advanced or Metastatic NSCLC Trial in Moscow, Saint Petersburg, St. Petersburg (Ceralasertib, Durvalumab)

      Recruiting
      • Advanced or Metastatic NSCLC
      • Moscow, Russian Federation
      • +7 more
      Jul 4, 2023

      Head Neck Cancer, Trismus, Dysfunction Trial in Temuco (Manual Therapy, Control motor exercises)

      Not yet recruiting
      • Head and Neck Cancer
      • +2 more
      • Manual Therapy
      • Control motor exercises
      • Temuco, Cautin, Chile
        Universidad de La Frontera
      Nov 17, 2023

      HER2-positive Breast Cancer Trial (Thero2-01S22, Placebo)

      Not yet recruiting
      • HER2-positive Breast Cancer
      • (no location specified)
      Jan 13, 2023